Kenvue Inc. $KVUE Shares Sold by Morningstar Investment Management LLC

Morningstar Investment Management LLC lessened its holdings in Kenvue Inc. (NYSE:KVUE) by 79.9% during the 4th quarter, Holdings Channel reports. The firm owned 174,656 shares of the company’s stock after selling 694,829 shares during the quarter. Morningstar Investment Management LLC’s holdings in Kenvue were worth $3,013,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently modified their holdings of KVUE. Arrowstreet Capital Limited Partnership purchased a new position in shares of Kenvue during the second quarter valued at approximately $6,528,000. Jump Financial LLC lifted its stake in shares of Kenvue by 210.6% during the second quarter. Jump Financial LLC now owns 54,823 shares of the company’s stock valued at $1,147,000 after buying an additional 37,170 shares during the period. AXA S.A. lifted its stake in shares of Kenvue by 21.1% during the second quarter. AXA S.A. now owns 48,892 shares of the company’s stock valued at $1,023,000 after buying an additional 8,524 shares during the period. NewEdge Advisors LLC lifted its stake in shares of Kenvue by 219.1% during the second quarter. NewEdge Advisors LLC now owns 97,481 shares of the company’s stock valued at $2,040,000 after buying an additional 66,930 shares during the period. Finally, The Manufacturers Life Insurance Company lifted its stake in shares of Kenvue by 0.6% during the second quarter. The Manufacturers Life Insurance Company now owns 1,873,705 shares of the company’s stock valued at $39,217,000 after buying an additional 10,885 shares during the period. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Analysts Set New Price Targets

KVUE has been the topic of several recent analyst reports. Zacks Research raised shares of Kenvue from a “hold” rating to a “strong-buy” rating in a research note on Friday, May 8th. Weiss Ratings raised shares of Kenvue from a “hold (c-)” rating to a “hold (c)” rating in a research note on Friday, May 8th. Barclays reduced their price objective on shares of Kenvue from $19.00 to $18.00 and set an “equal weight” rating on the stock in a research note on Tuesday, April 14th. UBS Group cut their price target on shares of Kenvue from $19.00 to $18.00 and set a “neutral” rating on the stock in a research note on Tuesday, April 7th. Finally, Argus raised shares of Kenvue to a “hold” rating in a research note on Friday, March 6th. One equities research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and twelve have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $19.33.

Kenvue Price Performance

Kenvue stock opened at $17.55 on Monday. Kenvue Inc. has a 52-week low of $14.02 and a 52-week high of $24.00. The firm has a fifty day moving average of $17.40 and a 200-day moving average of $17.43. The firm has a market capitalization of $33.69 billion, a P/E ratio of 20.64, a PEG ratio of 1.33 and a beta of 0.55. The company has a quick ratio of 0.70, a current ratio of 0.98 and a debt-to-equity ratio of 0.67.

Kenvue (NYSE:KVUE) last released its quarterly earnings results on Thursday, May 7th. The company reported $0.32 earnings per share for the quarter, beating analysts’ consensus estimates of $0.27 by $0.05. The business had revenue of $3.91 billion during the quarter, compared to analyst estimates of $3.84 billion. Kenvue had a net margin of 10.61% and a return on equity of 20.81%. The business’s revenue was up 4.5% on a year-over-year basis. During the same period last year, the business earned $0.24 EPS. As a group, analysts predict that Kenvue Inc. will post 1.16 EPS for the current year.

Kenvue Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, May 27th. Stockholders of record on Wednesday, May 13th will be given a $0.2075 dividend. This represents a $0.83 dividend on an annualized basis and a dividend yield of 4.7%. The ex-dividend date is Wednesday, May 13th. Kenvue’s dividend payout ratio (DPR) is presently 97.65%.

Insider Activity

In other news, General Counsel Matthew Orlando sold 38,491 shares of the firm’s stock in a transaction dated Friday, May 8th. The shares were sold at an average price of $17.66, for a total value of $679,751.06. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Insiders own 1.59% of the company’s stock.

About Kenvue

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.